Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
HJ Forman, H Zhang - Nature Reviews Drug Discovery, 2021 - nature.com
Oxidative stress is a component of many diseases, including atherosclerosis, chronic
obstructive pulmonary disease, Alzheimer disease and cancer. Although numerous small …
obstructive pulmonary disease, Alzheimer disease and cancer. Although numerous small …
KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
E Crisman, P Duarte, E Dauden… - Medicinal research …, 2023 - Wiley Online Library
The transcription factor nuclear factor erythroid 2‐related factor 2 (NRF2) is considered the
master regulator of the phase II antioxidant response. It controls a plethora of cytoprotective …
master regulator of the phase II antioxidant response. It controls a plethora of cytoprotective …
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
The endogenous metabolite itaconate has recently emerged as a regulator of macrophage
function, but its precise mechanism of action remains poorly understood,,. Here we show …
function, but its precise mechanism of action remains poorly understood,,. Here we show …
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Metabolic reprogramming has become a key focus for both immunologists and cancer
biologists, with exciting advances providing new insights into the mechanisms underlying …
biologists, with exciting advances providing new insights into the mechanisms underlying …
The role of astrocytes in multiple sclerosis
The role traditionally assigned to astrocytes in the pathogenesis of multiple sclerosis (MS)
lesions has been the formation of the glial scar once inflammation has subsided. Astrocytes …
lesions has been the formation of the glial scar once inflammation has subsided. Astrocytes …
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL
A Schmitt, W Xu, P Bucher, M Grimm… - Blood, The Journal …, 2021 - ashpublications.org
Despite the development of novel targeted drugs, the molecular heterogeneity of diffuse
large B-cell lymphoma (DLBCL) still poses a substantial therapeutic challenge. DLBCL can …
large B-cell lymphoma (DLBCL) still poses a substantial therapeutic challenge. DLBCL can …
Tricarboxylic acid (TCA) cycle intermediates: regulators of immune responses
I Choi, H Son, JH Baek - Life, 2021 - mdpi.com
The tricarboxylic acid cycle (TCA) is a series of chemical reactions used in aerobic
organisms to generate energy via the oxidation of acetylcoenzyme A (CoA) derived from …
organisms to generate energy via the oxidation of acetylcoenzyme A (CoA) derived from …
Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS)
S Glatigny, E Bettelli - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Multiple sclerosis (MS) is a multifocal demyelinating disease of the central nervous system
(CNS) leading to the progressive destruction of the myelin sheath surrounding axons. It can …
(CNS) leading to the progressive destruction of the myelin sheath surrounding axons. It can …
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
U Schulze-Topphoff, M Varrin-Doyer… - Proceedings of the …, 2016 - National Acad Sciences
Dimethyl fumarate (DMF)(BG-12, Tecfidera) is a fumaric acid ester (FAE) that was advanced
as a multiple sclerosis (MS) therapy largely for potential neuroprotection as it was …
as a multiple sclerosis (MS) therapy largely for potential neuroprotection as it was …
The immunomodulatory potential of the metabolite itaconate
A Hooftman, LAJ O'Neill - Trends in immunology, 2019 - cell.com
The field of immunometabolism has demonstrated that metabolites can lead double lives as
immunomodulators. Itaconate is perhaps the best example of such a moonlighting molecule …
immunomodulators. Itaconate is perhaps the best example of such a moonlighting molecule …